Mast cell–derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice
Authors:
- Motoyasu IikuraMIMotoyasu Iikura
- Stephen J. GalliSGStephen J. Galli
- 1 July 2007
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 120 (1) , 48-55
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Tumour necrosis factor (TNF ) as a novel therapeutic target in symptomatic corticosteroid dependent asthmaThorax, 2005
- What targets have knockouts revealed in asthma?Pharmacology & Therapeutics, 2005
- Mast Cell-Deficient W-sash c-kit Mutant KitW-sh/W-sh Mice as a Model for Investigating Mast Cell Biology in VivoThe American Journal of Pathology, 2005
- No audible wheezingJournal of Experimental Medicine, 2005
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Murine models of asthmaEuropean Respiratory Journal, 2003
- The IL‐1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma modelEuropean Journal of Immunology, 2003
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elementsImmunology & Cell Biology, 1998
- Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses.Journal of Experimental Medicine, 1991